CMTA News
![Actio Bio receives FDA Orphan Drug Designation and Rare Pediatric Disease Designation.](https://www.cmtausa.org/wp-content/uploads/2024/08/actio-650-x-400.png)
CMTA-STAR Alliance Partner Actio Biosciences Receives FDA Orphan Drug Designation and Rare Pediatric Disease Designation for Their Treatment in Development for CMT2C
What is CMT?
![](http://www.cmtausa.org/wp-content/themes/twentyseventeen-child/assets/images/cmta-home-informational-hero.jpg))
Living With CMT
CMT doesn’t have to stop you from doing the things you want to do. We have ...
Living with CMTResearching the Cure
Over $23.5 million invested in STAR research driving our vision of a world without CMT ..
Our Research![](http://www.cmtausa.org/wp-content/themes/twentyseventeen-child/assets/images/cmta-home-support.png)
Make a Difference,
Support CMT Research
Currently, there is no cure for CMT, but we can change that with your support. Donate now and help us accelerate research to develop treatments and a cure for CMT.
Donate